Integration of transcriptomics, proteomics and loss-of-function screening reveals WEE1 as a target for combination with dasatinib against proneural glioblastoma - Alhalabi, Obada; Göttmann, Mona; Gold, Maxwell P.; Schlue, Silja; Hielscher, Thomas; Iskar, Murat; Keßler, Tobias; Hai, Ling; Lokumcu, Tolga; Cousins, Clara C.; Herold-Mende, Christel; Heßling, Bernd; et al. (Cancer letters, 2024)
Online verfügbar: 25. September 2024, Artikelversion: 3. Oktober 2024